<DOC>
	<DOCNO>NCT00317707</DOCNO>
	<brief_summary>In everyday practice cardiovascular prevention people high risk still unsatisfactory treatment document efficacy generally under-used . Polyunsaturated fatty acid marine origin ( n-3 PUFA ) late promise strategy improve prognosis patient . The Risk Prevention study combine epidemiological experimental approach order : 1 . Verify possibility optimise cardiovascular prevention subject high risk plan intervention patient set individual goal ( outcome study ) 2 . Evaluate efficacy long term n-3 PUFA treatment reduce incidence cardiovascular event , control , randomise , double blind clinical trial .</brief_summary>
	<brief_title>Risk Prevention Study : Evaluation Efficacy n-3 PUFA Subjects High Cardiovascular Risk</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Multiple risk factor : diabetes , age = &gt; 65 year , male sex , hypertension , hypercholesterolemia , smoking , obesity , family history premature cardiovascular disease ; Previous manifestation atherosclerotic disease ( ischemic stoke , transient ischemic attack [ TIA ] , peripheral artery disease , previous arterial revascularisation procedure , angina pectoris ) Contraindications ( know allergy n3 PUFA ) indication ( previous myocardial infarction ) treatment n3 PUFA Serious comorbidity unfavourable prognosis short term Expected non compliance long period time Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>cardiovascular risk</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>cardiovascular prevention</keyword>
	<keyword>polyunsaturated fatty acid</keyword>
	<keyword>diabetes</keyword>
	<keyword>hypertension</keyword>
	<keyword>hypercholesterolemia</keyword>
	<keyword>obesity</keyword>
</DOC>